Fop-Acvr1 Signals By Multiple Modalities In The Developing Zebrafish
Degree type
Graduate group
Discipline
Subject
BMP
Fibrodysplasia ossificans progressiva
Zebrafish
Developmental Biology
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Contributor
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare human genetic disorder characterized by skeletal malformations and progressive extraskeletal ossification. All cases of FOP are caused by activating mutations in the GS or kinase domains of the type I BMP/TGFβ cell surface receptor, ACVR1, which over-activate signaling through phospho-Smad1/5 (pSmad1/5). To investigate the uncertain mechanism by which FOP-ACVR1 enhances pSmad1/5 activation, we used a zebrafish embryonic dorsoventral (DV) patterning assay for BMP signaling. In this system, misexpression of human ACVR1-R206H causes increased pSmad1/5 signaling and ventralization of zebrafish embryos. To pattern the zebrafish DV axis, Acvr1l, the zebrafish homologue of human ACVR1, signals in response to BMP ligand within a heterotetrameric, type I and II receptor complex. Previous studies have demonstrated that type II BMP receptors are required for the activity of FOP-ACVR1, however the roles of ligand and other type I BMP receptors are less well understood. We determined that the FOP mutants ACVR1-R206H and -G328R do not require their ligand binding domain to over-activate BMP signaling in DV patterning. However, intact ACVR1-R206H and G328R have the ability to respond to BMP ligand. Additionally, BMPR1, a type I BMP receptor which is normally required for BMP-mediated patterning of the embryo, is dispensable for both ligand-independent and ligand-responsive BMP signaling activation by ACVR1-R206H. Both ACVR1-R206H and -G328R require a GS domain, and presumptive type II BMP receptor activity. However, ACVR1-R206H and -G328R have a reduced requirement for serine and threonine residues within the GS domain compared to ACVR1. Interestingly, these FOP mutants, differ from each other in their GS domain residue requirements for ligand-independent signaling. Over-active signaling by ACVR1-R206H and -G328R can be abrogated by competitive ATP inhibition, confirming that kinase activity is required for over-active signaling. Lastly, Acvr1l-R203H, the zebrafish homolog of ACVR1-R206H, does not have over-active signaling. However, the human ACVR1 kinase domain is sufficient to facilitate over-active signaling by Acvr1l-R203H. These data provide new insight into how the ligand-receptor complex assembles and is regulated in both wild-type and FOP BMP pathway signaling and elucidate potential targets for the treatment of FOP.
Advisor
Eileen M. Shore